Navigation Links
Centralized Holter Analysis

ProductsCentralized Holter Analysis
Company Philips Medical Systems
Item Centralized Holter Analysis
Features 
  • Send ECG data via email, LAN or WAN using Philips Zymed Remote Link
  • Central Holter Analysis Site where Philips Zymed Central Link and a Holter analysis application are loaded on PCs
  • Analyzed Holter reports returned to sender
    • Description Philips Zymed communications software, including Remote Link and Central Link, is open, secure and scalable, giving you the tools and choices to effectively centralize Holter recording analysis and report access. Send patient tests via email, LAN or WAN to a central analysis location where Philips Zymed Holter analysis applications are used. The streamlined process eliminates the delay and expense associated with couriers and overnight shipping, and reduces staff training needs and equipment maintenance costs.
    Info Philips Medical SystemsCall Philips Medical Systems to buy products (US and Canada only; other locations use number below) USACanada1-866-745-0519

    Customer Service: 1-800-722-7900
    Web site: http://www.medical.philips.com/

    Related medicine products :

    1. Endoalpha Centralized O.R. Control System
    2. AB-180R Digital Holter Recorder
    3. cardiomemory RAC-1202 Compact Holter Recorder
    4. Lifecard 12 Digital Holter Recorder
    5. Q-Track II Holter Monitoring System
    6. Q-Track i Holter Monitoring System
    7. Premier 12 Holter Analysis Kit
    8. Vision 5L Digital Holter Recorder
    9. Vision Premier Holter Analysis Systems
    10. Vision Holter Analysis System
    11. IQmark EZ Holter
    Breaking Medicine News(10 mins):Health News:Hard to Treat Diseases (HTDS.PK) Business Summary Update 2Health News:Hard to Treat Diseases (HTDS.PK) Business Summary Update 3Health News:Hard to Treat Diseases (HTDS.PK) Business Summary Update 4Health News:Quantros(TM) Unveils Clinical Cafe, Social Networking Website for Healthcare Professionals Focused on Safety, Quality and Compliance 2Health News:Quantros(TM) Unveils Clinical Cafe, Social Networking Website for Healthcare Professionals Focused on Safety, Quality and Compliance 3Health News:Delinquent boys at increased risk of premature death and disability by middle age 2Health News:Delinquent boys at increased risk of premature death and disability by middle age 3Health News:BridgeGate International Announces New Integration and Interoperability Training Program 2Health News:BridgeGate International Announces New Integration and Interoperability Training Program 3Health News:BridgeGate International Announces New Integration and Interoperability Training Program 4Health News:Sex Talk Taking Place After the Fact 2Health News:Sex Talk Taking Place After the Fact 3
    Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Mirixa Corporation Announces Key New Hires 12958 1Mirixa Corporation Announces Key New Hires 12958 2Landmark project to map genomics of complex ant systems 9188 1Landmark project to map genomics of complex ant systems 9188 2European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2